Your Health, We Care

Home > Photo Wall > Honor and qualification

Production approval for Dabrafenib

Release date: 2024-07-10 15:18:37     Recommended: 152

10L1025_23 达拉非尼 批文_00.jpg

Used for melanoma with BRAFV600E or V600K mutation positivity that cannot be resected or metastasized, while melanoma with V600K mutation positivity that cannot be resected or metastasized must be used in combination with trametinib.

Company News

Research News

Drug news